News

The book celebrates leadership and innovation and covers bit.bio's ambition to engineer the future of medicine. 

Short film showcases innovative cell reprogramming technology at event.

Find out why animals are not always ideal when studying potential treatments for diseases like Alzheimer's.

This piece covers what's different about our cell coding approach.

MP Anthony Browne visits bit.bio's labs and offices to officially open facilities.

bit.bio's Founder and CEO Mark Kotter talks to Kurier about reprogramming cells for therapies.

Read about the Babraham Investor Conference 2021 focusing on early-stage and scale-up life science and med-tech companies.

This piece focuses on the promise of stem cells for cell therapies.